{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:40Z","timestamp":1793293120394,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T10:49:36Z","timestamp":1540378176000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The protective effect of rifampicin on behavioral deficits, biochemical, and neuropathological changes in a cuprizone model of demyelination"],"prefix":"10.1016","volume":"113","author":[{"given":"Hamid","family":"Zahednasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Firouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sussan","family":"Kaboudanian-Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mojallal-Tabatabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Karampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2018.10.016_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1750-3639.2005.tb00523.x","article-title":"Multiple sclerosis pathology: evolution of pathogenetic concepts","volume":"15","author":"Lassmann","year":"2005","journal-title":"Brain Pathol."},{"issue":"6","key":"10.1016\/j.cyto.2018.10.016_b0010","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","article-title":"Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation","volume":"123","author":"Bitsch","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2018.10.016_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Develop. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cyto.2018.10.016_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of multiple sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2018.10.016_b0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2018.10.016_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/lungindia.lungindia_451_15","article-title":"Multidrug-resistant tuberculosis and leprosy: an unsolved mystery","volume":"34","author":"Gupta","year":"2017","journal-title":"Lung India: Off. Organ of Indian Chest Soc."},{"key":"10.1016\/j.cyto.2018.10.016_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2014.05.007","article-title":"RIFAMPICIN: an antibiotic with brain protective function","volume":"107","author":"Yulug","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cyto.2018.10.016_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2015.06.008","article-title":"Rifampicin attenuates rotenone-induced inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"1622","author":"Liang","year":"2015","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2017.01.100","article-title":"Rifampicin pre-treatment inhibits the toxicity of rotenone-induced PC12 cells by enhancing sumoylation modification of \u03b1-synuclein","volume":"485","author":"Lin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2018.10.016_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.12637","article-title":"The therapeutic role of Rifampicin in Alzheimer's disease","author":"Yulug","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0060","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J. Lab. Clin. Med."},{"issue":"6","key":"10.1016\/j.cyto.2018.10.016_b0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/BF02653674","article-title":"A new thiobarbituric acid (TBA) method for determining free malondialdehyde (MDA) and hydroperoxides selectively as a measure of lipid peroxidation","volume":"66","author":"Schmedes","year":"1989","journal-title":"J. Am. Oil Chem. Soc."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cyto.2018.10.016_b0080","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.12659\/MSM.903842","article-title":"Olig2 Silence ameliorates cuprizone-induced schizophrenia-like symptoms in mice","volume":"23","author":"Liu","year":"2017","journal-title":"Med. Sci. Monit: Int. Med. J. Experiment. Clin. Res."},{"issue":"2","key":"10.1016\/j.cyto.2018.10.016_b0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12264-013-1323-1","article-title":"Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit","volume":"29","author":"Wang","year":"2013","journal-title":"Neurosci. Bull."},{"issue":"7","key":"10.1016\/j.cyto.2018.10.016_b0090","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1007\/s12035-015-9404-y","article-title":"The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination","volume":"53","author":"Vakilzadeh","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"issue":"5547","key":"10.1016\/j.cyto.2018.10.016_b0100","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cyto.2018.10.016_b0105","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jnc.13871","article-title":"Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses","volume":"139","author":"Ma","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.cyto.2018.10.016_b0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/joc.2004.16.4.357","article-title":"Immunomodulating activity of rifampicin","volume":"16","author":"Ziglam","year":"2004","journal-title":"J. Chemother."},{"key":"10.1016\/j.cyto.2018.10.016_b0115","doi-asserted-by":"crossref","first-page":"12337","DOI":"10.1038\/srep12337","article-title":"Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods","volume":"5","author":"Kandasamy","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1014256603539","article-title":"Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis","volume":"22","author":"Yerramasetti","year":"2002","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2018.10.016_b0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"2\u20133","key":"10.1016\/j.cyto.2018.10.016_b0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-510X(88)90127-X","article-title":"Cuprizone neurotoxicity in the rat: morphologic observations","volume":"84","author":"Love","year":"1988","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2018.10.016_b0135","doi-asserted-by":"crossref","first-page":"e92110","DOI":"10.1371\/journal.pone.0092110","article-title":"Rifampicin protects PC12 cells from rotenone-induced cytotoxicity by activating GRP78 via PERK-eIF2alpha-ATF4 pathway","volume":"9","author":"Jing","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.cyto.2018.10.016_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2017.09.034","article-title":"Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL\/6 mouse model of cuprizone-induced demyelination","volume":"1678","author":"Yu","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nm0198-092","article-title":"The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor","volume":"4","author":"Calleja","year":"1998","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cyto.2018.10.016_b0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1567-5769(03)00022-5","article-title":"Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-\u03b1 production","volume":"3","author":"Mlambo","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"19","key":"10.1016\/j.cyto.2018.10.016_b0155","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1242\/jcs.03160","article-title":"ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1","volume":"119","author":"Shiraishi","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cyto.2018.10.016_b0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuint.2015.08.015","article-title":"The cuprizone-induced changes in 1H-MRS metabolites and oxidative parameters in C57BL\/6 mouse brain: effects of quetiapine","volume":"90","author":"Xuan","year":"2015","journal-title":"Neurochem. Int."},{"issue":"12","key":"10.1016\/j.cyto.2018.10.016_b0165","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","article-title":"Inhibition of amyloid protein aggregation and neurotoxicity by rifampicin its possible function as a hydroxyl radical scavenger","volume":"271","author":"Tomiyama","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.15.1.8679227","article-title":"Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury","volume":"15","author":"Choi","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2018.10.016_b0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<652::AID-JNR11>3.0.CO;2-5","article-title":"Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury","volume":"56","author":"Le","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12035-014-8857-8","article-title":"Protective effect of a cAMP analogue on behavioral deficits and neuropathological changes in cuprizone model of demyelination","volume":"52","author":"Vakilzadeh","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.016_b0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.cyto.2018.10.016_b0190","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","article-title":"Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions","volume":"164","author":"Mason","year":"2004","journal-title":"Am. J. Pathol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:00Z","timestamp":1760907060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618304046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":38,"alternative-id":["S1043466618304046"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effect of rifampicin on behavioral deficits, biochemical, and neuropathological changes in a cuprizone model of demyelination","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}